NO20035572L - Process for preparing the piperidine derivative fexofenadine - Google Patents

Process for preparing the piperidine derivative fexofenadine

Info

Publication number
NO20035572L
NO20035572L NO20035572A NO20035572A NO20035572L NO 20035572 L NO20035572 L NO 20035572L NO 20035572 A NO20035572 A NO 20035572A NO 20035572 A NO20035572 A NO 20035572A NO 20035572 L NO20035572 L NO 20035572L
Authority
NO
Norway
Prior art keywords
fexofenadine
preparing
piperidine derivative
piperidine
derivative
Prior art date
Application number
NO20035572A
Other languages
Norwegian (no)
Other versions
NO20035572D0 (en
Inventor
Collin Schroeder
Ryan Huddleston
Richard Charles
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20035572D0 publication Critical patent/NO20035572D0/en
Publication of NO20035572L publication Critical patent/NO20035572L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20035572A 2001-06-15 2003-12-12 Process for preparing the piperidine derivative fexofenadine NO20035572L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29839701P 2001-06-15 2001-06-15
PCT/EP2002/006424 WO2002102776A1 (en) 2001-06-15 2002-06-12 Process for the production of the piperidine derivative fexofenadine

Publications (2)

Publication Number Publication Date
NO20035572D0 NO20035572D0 (en) 2003-12-12
NO20035572L true NO20035572L (en) 2004-02-16

Family

ID=23150325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035572A NO20035572L (en) 2001-06-15 2003-12-12 Process for preparing the piperidine derivative fexofenadine

Country Status (23)

Country Link
US (2) US6743941B2 (en)
EP (1) EP1401816B1 (en)
JP (1) JP4344230B2 (en)
KR (1) KR100903285B1 (en)
CN (1) CN1229347C (en)
AR (1) AR037005A1 (en)
AT (1) ATE386021T1 (en)
AU (1) AU2002320847B2 (en)
BR (1) BR0210410A (en)
CA (1) CA2450313C (en)
DE (1) DE60225008T2 (en)
DK (1) DK1401816T3 (en)
ES (1) ES2298384T3 (en)
HK (1) HK1063795A1 (en)
HU (1) HUP0401125A2 (en)
IL (2) IL159304A0 (en)
MX (1) MXPA03010960A (en)
NO (1) NO20035572L (en)
NZ (1) NZ530153A (en)
PL (1) PL364369A1 (en)
PT (1) PT1401816E (en)
WO (1) WO2002102776A1 (en)
ZA (1) ZA200308697B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
CN100453522C (en) * 2005-01-26 2009-01-21 中国科学技术大学 Preparation of 4-[4-(1-oxethylacyl-1-ethyl methyl benzene)]-4-ketobutyric acid
WO2007135693A2 (en) * 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermediates useful for the preparation of antihistaminic piperidine derivative
ITMI20061492A1 (en) * 2006-07-27 2008-01-28 Archimica Srl PROCESS FOR THE PREPARATION OF FEXOPHENADINE.
ITMI20061491A1 (en) * 2006-07-27 2008-01-28 Archimica Srl PROCESS FOR THE PREPARATION OF FEXOPHENADINE.
CN102070570A (en) * 2009-11-21 2011-05-25 浙江华海药业股份有限公司 2-methyl-2(4-(2-oxo-tetrahydrofuran-3-carbonyl)phenyl)propionitrile of fexofenadine intermediate and preparation method for salt thereof
CN102070490B (en) * 2009-11-21 2014-07-30 浙江华海药业股份有限公司 Method for preparing fexofenadine intermediate 2-(4-(4-maloyl) phenyl)-2-methylpropionitrile
EP3842429B1 (en) 2015-06-15 2022-09-07 Asana BioSciences, LLC Heterocyclic inhibitors of erk1 and erk2 and their use in the treatment of cancer
CN104876853B (en) * 2015-06-17 2017-06-16 苏州卫生职业技术学院 The synthetic method of fexofenadine hydrochloride
ES2770341T3 (en) 2015-10-22 2020-07-01 Sanofi Aventis Deutschland Process for the preparation of fexofenadine and the intermediates used in it
EP4051264A1 (en) 2019-10-28 2022-09-07 Asana BioSciences, LLC Improved methods, kits, compositions and dosing regimens for the use of heterocyclic inhibitors of erk1 and erk2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2946809A1 (en) * 1979-11-20 1981-06-11 A. Nattermann & Cie GmbH, 5000 Köln 3-Benzoyl-propionic acid derivs. - useful as non-ulcerogenic antiinflammatory agents
IT1200123B (en) 1985-09-27 1989-01-05 Ind Chimica Srl PROCESS FOR ALPHA PREPARATION
EP0347123A3 (en) 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties
IT1249684B (en) 1991-07-19 1995-03-09 Sorin Biomedica Spa HEPATITIS VIRUS PROTEIN ENV EPITOPES
MX9302076A (en) * 1992-04-10 1994-03-31 Merrell Dow Pharma A NEW PROCESS TO PREPARE PIPERIDINE DERIVATIVES.
WO1995000482A1 (en) 1993-06-24 1995-01-05 Albany Molecular Research, Inc. Piperidine derivatives and process for their production

Also Published As

Publication number Publication date
AU2002320847B2 (en) 2007-09-20
NO20035572D0 (en) 2003-12-12
IL159304A (en) 2010-02-17
CA2450313C (en) 2010-08-10
ES2298384T3 (en) 2008-05-16
EP1401816B1 (en) 2008-02-13
US6743941B2 (en) 2004-06-01
NZ530153A (en) 2005-07-29
CA2450313A1 (en) 2002-12-27
BR0210410A (en) 2004-08-17
MXPA03010960A (en) 2004-02-27
HUP0401125A2 (en) 2004-09-28
PT1401816E (en) 2008-04-08
DE60225008D1 (en) 2008-03-27
DK1401816T3 (en) 2008-06-09
JP2005502603A (en) 2005-01-27
EP1401816A1 (en) 2004-03-31
AR037005A1 (en) 2004-10-20
KR100903285B1 (en) 2009-06-17
PL364369A1 (en) 2004-12-13
IL159304A0 (en) 2004-06-01
CN1229347C (en) 2005-11-30
WO2002102776A1 (en) 2002-12-27
ATE386021T1 (en) 2008-03-15
US20030105329A1 (en) 2003-06-05
US7235665B2 (en) 2007-06-26
DE60225008T2 (en) 2009-01-29
US20040198983A1 (en) 2004-10-07
ZA200308697B (en) 2004-09-03
KR20040010720A (en) 2004-01-31
JP4344230B2 (en) 2009-10-14
CN1516689A (en) 2004-07-28
HK1063795A1 (en) 2005-01-14

Similar Documents

Publication Publication Date Title
ATE507201T1 (en) ENERGY-EFFECTIVE CARBONYLATION PROCESS
HK1072251A1 (en) Piperidine derivative
IS5982A (en) Process for the preparation of 5-cyanothalide
IS5715A (en) Method for the construction of 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
IS6487A (en) Method for the production of Citalopram
IS2590B (en) Process for the synthesis of a benzimidol-sulfur compound
ID28724A (en) PROCESS FOR PRODUCING CYCLALONEON
IS7239A (en) Process for the production of acitalopram
NO20035572L (en) Process for preparing the piperidine derivative fexofenadine
IS7153A (en) A process for the preparation of a 14-hydroxynormorphinone derivative
FI20011889A0 (en) Process for the preparation of xylitol
DK1362040T3 (en) Process for preparing mesylates of piperidine derivatives
NO20041850L (en) Process for Forming Prophene Crystals
ID29787A (en) PROCESS FOR PRODUCING RICH-METHAN LIQUID
MXPA03009806A (en) Process for producing purified piperidine derivative.
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
NO20001134D0 (en) Process for manufacturing VCM
NO20043760L (en) Process for producing olefins
ID30126A (en) METHODS FOR PRODUCING SIKLO- (Asp-DPhe-NMeVal-Arg-Gly)
FI20011563A (en) Arrangement for the production site
EE200300204A (en) Process for the preparation of a distamycin derivative
NO20035138D0 (en) Process for the preparation of amorphous sodium silastatin
IS5212A (en) Improved method for the preparation of pyrazolopyrimidinone derivative
DE10394362D2 (en) Method for the operation of a technical system
NO20033432D0 (en) Indoline derivative and process for preparing the same